As Wall Street looks beyond near-term volatility and into 2026, Bank of America is starting to draw clear lines between stocks that may simply survive and those it believes can still compound returns.
In a recent round of analyst notes, the firm highlighted several companies it views as best ideas for 2026, spanning artificial intelligence, life sciences, industrial technology, global banking, and consumer beauty. The common theme is improving fundamentals, easing headwinds, and identifiable catalysts that could drive earnings growth over the next two years.
For investors, this list offers a window into where one of the largest U.S. banks sees durable opportunity as the market transitions from hype-driven trades to earnings-driven performance.
Nvidia: Still the Center of the AI Trade
Despite periodic concerns about overinvestment in artificial intelligence infrastructure, Bank of America remains firmly bullish on Nvidia heading into 2026.
The firm acknowledges what it describes as “mid-age blues” in AI spending but expects growth to reaccelerate rather than stall. According to the bank, AI semiconductor revenue could post another year of more than 50 percent year-over-year growth, driven by rising data center utilization, tight chip supply, accelerating enterprise adoption, and an ongoing race among hyperscalers, sovereign buyers, and large language model developers.
“Mid-age blues in AI investments, but we forecast another year of solid 50%+ YoY growth in AI semis driven by strong data center utilization, tight supply, enterprise adoption and race between LLM-builders, hyperscale and sovereign customers. Leader NVDA trading at compelling 24x/18x CY26/27E PE, half of its growth-rate, with solid pipeline and catalysts.”
From a valuation standpoint, Bank of America argues Nvidia is no longer priced like a speculative momentum stock. Instead, it trades at multiples the bank views as reasonable given its growth profile and dominant market position.
Why it matters for investors: Nvidia remains the primary lever for exposure to AI infrastructure. Even if AI spending normalizes, Bank of America believes Nvidia’s pricing power, product pipeline, and entrenched ecosystem position it to remain a long-term compounder rather than a boom-and-bust trade.
Bruker: A Life Sciences Recovery Play
Bruker, a life sciences and biotechnology instrumentation company, is another name Bank of America believes is setting up well for 2026.
After meeting with management, analyst Michael Ryskin said he came away more optimistic about an anticipated recovery across the life sciences tools market. The firm sees improving end-market conditions and signs that key headwinds are beginning to fade.
“We came away more encouraged by the anticipated 2026 recovery, both for the broader LS Tools market and BRKR specifically. BRKR sees headwinds fading in most key end markets, and cited encouraging trends in 3Q.”
Ryskin also raised his price target on Bruker to $60 per share from $43, signaling increased confidence in the company’s earnings trajectory.
Shares are already up about 7 percent over the past month, but Bank of America believes the move reflects early recognition of improving fundamentals rather than a full valuation reset.
Why it matters for investors: Life sciences spending has been under pressure due to funding constraints and inventory adjustments. Bank of America’s view suggests Bruker could benefit as budgets stabilize and demand rebounds, offering exposure to a cyclical recovery without relying on consumer spending or macro stimulus.
Estée Lauder: Turnaround Momentum Into 2026
Bank of America also sees opportunity in Estée Lauder, naming the beauty company to its US1 top picks list.
Analyst Ashley Wallace believes the company is well positioned to benefit from improving beauty demand globally, particularly as it executes a turnaround focused on innovation, new distribution channels, and operational efficiency.
“Estée Lauder is most leveraged to the parts of beauty demand which are improving in 2026.”
The bank raised its price target to $130 per share from $120, reflecting confidence in the company’s strategic reset.
“We think success can be had in speeding up innovation cycle, entering new channels and redeploying cost savings back into consumer facing investment.”
The stock is already up roughly 44 percent this year, but Bank of America argues that improved execution and international growth could sustain momentum beyond the initial rebound.
Why it matters for investors: Estée Lauder offers exposure to global consumer demand without relying heavily on U.S. discretionary spending alone. If management delivers on innovation and channel expansion, margins and earnings growth could surprise to the upside in 2026.
UBS: A Global Banking Standout
UBS is Bank of America’s preferred global bank heading into 2026, earning a buy rating upgrade and inclusion on both its U.S. and European top picks lists.
Analyst Antonio Reale highlighted UBS’s combination of potential regulatory relief and strong growth in wealth management and capital markets.
“Time to buy. The end-result UBS is a highly attractive proposition, and the equity story combines the potential for more lenient capital requirements with areas of strong growth in wealth and capital markets.”
Reale also noted that UBS’s earnings per share growth is expected to outpace that of any other global bank.
“EPS is set to grow sequentially at the fastest pace of any bank globally.”
Shares are already up about 32 percent this year, but Bank of America believes the structural growth story remains intact.
Why it matters for investors: UBS offers diversified exposure to global wealth creation, investment banking, and capital markets. If capital requirements ease and market activity improves, earnings leverage could remain strong well into 2026.
Ametek: Industrial Growth With Pricing Power
Ametek rounds out Bank of America’s list as an industrial name positioned for renewed growth.
The company manufactures highly engineered components for niche markets, giving it strong pricing power even in uneven economic environments. Bank of America notes that many of Ametek’s equipment customers went through significant destocking in 2025, a process that now appears to be complete.
Organic orders rose 7 percent year over year in the third quarter of 2025, marking the fastest growth since the third quarter of 2022.
Why it matters for investors: Ametek provides exposure to industrial recovery without relying on broad commodity cycles. As destocking ends and order growth accelerates, earnings visibility improves, which can support higher valuations.
The Bigger Picture for Investors
What ties these picks together is not hype, but visibility.
Bank of America is signaling that 2026 could reward companies with clear earnings drivers, improving fundamentals, and pricing power rather than speculative growth narratives. Nvidia represents durable leadership in AI, while Bruker and Ametek offer cyclical recovery exposure. Estée Lauder and UBS reflect confidence in operational turnarounds and global financial activity.
For investors building positions with a multi-year horizon, this list provides a useful framework for identifying where institutional capital may continue to flow as the market looks beyond 2025.
In short, Bank of America is betting that select leaders across technology, industry, finance, and consumer goods still have room to run and that patience could be rewarded.
About Author
